title: [Effectiveness of duspatalin therapy in the treatment and prevention of post-cholecystectomy syndrome].
abstract: Results of evaluation of the efficiency of myotropic spasmolytic Duspatalin during long-term therapy and preventive treatment of functional post-cholecystectomy syndrome are presented. The influence of the treatment on manifestations of clinical symptoms, quality of a life estimated based on a visual-analog scale, and intestinal microbiocenosis (changes in the activity of short-chain fatty acids) are discussed.
authors.forename: E M
authors.initials: EM
authors.lastname: Lipnitskiĭ
authors.forename: O V
authors.initials: OV
authors.lastname: Isakova
authors.forename: V A
authors.initials: VA
authors.lastname: Movchun
authors.forename: M D
authors.initials: MD
authors.lastname: Apdatskaia
mesh_terms: D000328:Adult; D000368:Aged; D018988:Bacterial Translocation / Q000187:drug effects*; D058448:Biota; D003248:Constipation / Q000139:chemically induced; D003362:Cost-Benefit Analysis; D018592:Cross-Over Studies; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000008:administration & dosage / Q000009:adverse effects; D010627:Phenethylamines / Q000008:administration & dosage / Q000009:adverse effects; D017562:Postcholecystectomy Syndrome / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology*; D011788:Quality of Life; D009803:Sphincter of Oddi / Q000187:drug effects*; D016896:Treatment Outcome
chemical_list: D010276:Parasympatholytics; D010627:Phenethylamines; C005096:mebeverine